Sleep well to recover well to perform well. Athletes have been considering this issue for a long time. Margaux de Frouville and Alain Ducardonnet receive Mathieu Nédélec, doctor in sports sciences at INSEP, ex-physical trainer and co-author of “Sleep better thanks to the secrets of great athletes” published by Vuibert.
When we say illness, we often think of medication. Few of us imagine leaving a consultation without the life-saving prescription, medication, but not only because over the last ten years additional solutions have become essential. The High Authority of Health has given them a name since 2011: INMs. Adapted physical activities, psychotherapies, hypnotherapy, targeted diets, therapeutic education and many others are known, used and acclaimed by the general public. But we must recognize that these INMs still raise questions: plethora of techniques, effectiveness not clearly demonstrated, trained and competent professionals difficult to identify, playground for certain charlatans… What do we mean by INM? What effectiveness has been demonstrated? Who should I turn to to benefit from it? What does the science say and have the doubts spurred the research? The answers of Professor Grégory Ninot, professor at the University of Montpellier and president of the international society of INMs, president of the Non-pharmacological intervention society (NPIS), professor at the University of Montpellier, deputy director of the Desbrest Institute of epidemiology and public health at INSERM, research fellow at the Montpellier Cancer Institute and Member of the University Institute of France.
Of the 60,000 breast cancers detected in women in 2023, nearly a third were treated by breast removal, mastectomy. However, breast reconstruction still remains little known, or even difficult to access. Specialists estimate the number of women who would like reconstruction but do not do it at 70,000. Doctor Isabelle Sarfati, plastic surgeon and founder of the Sien Institute in Paris, and Professor Michaël Atlan, head of the reconstructive and aesthetic plastic surgery department at Tenon hospital, answer questions from Margaux de Frouville and Alain Ducardonnet .
You have known him for 7 years, he informs us with his letters and colors placed on certain food products. The Nutriscore stood out as a simple translation of their composition. Its goal for the consumer: to understand more easily the nutritional quality of foods and to be able to compare them within the same family. Except that it has just undergone, at the start of the year, a change in its method of calculation. What is the new Nutriscore calculation based on? What foods are affected? Is it understood by consumers? Why are some manufacturers reluctant to adopt it or even leave it? With what consequences? The father of this nutri-score, Professor Serge Hercberg, Professor Emeritus at Sorbonne Paris Nord University and for 18 years president of the PNNS national nutrition and health program, is the guest of Margaux de Frouville and Alain Ducardonnet.
Where did I put the keys? And besides, did I close the door? Who is he again? What was our dinner menu yesterday? If you have ever asked yourself any of these questions or if you ask yourself them regularly, don’t panic, you are not alone. Forgetting would be a desirable phenomenon for our memory, an essential but complex function of our brain. It allows us to integrate, store and restore information to interact with our environment. When we say memory, we first think of memories, but also of knowledge and know-how. How does memory work? Can we stimulate it? Who are his friends and his enemies? When should we be concerned about omissions? To answer these questions Margaux de Frouvillet and Alain Ducardonnet receive Bruno Dubois, professor of neurology, director of the center for Cognitive and Behavioral Diseases at the Salpêtrière Hospital and Florian Manicardi, vice-champion of France in memory 2022, author of the book A champion’s memory from Editions Alisio.
A runny nose, frequent cough, sometimes wheezing, meals less well eaten… Bronchiolitis represents stress for parents of young children. Stress linked in the overwhelming majority of cases to RSV, the Respiratory Syncytial Virus. Before the age of two, one in three babies has been exposed to it and 2 to 3% must be hospitalized. Last winter, the epidemic was marked by its precocity and its duration: 3 months. But a lesser hospital impact, the Pasteur Institute estimated in a modeling that around 5,800 hospitalizations were avoided thanks to nirsevimab, known by the trade name Beyfortus. 250,000 babies benefited from this monoclonal antibody injection. With unexpected support from parents. This year, 600,000 doses have been ordered. And a new weapon is available to parents since an anti-RSV vaccine can be administered in the eighth month of pregnancy. What is the difference between these two means of prevention? Is one more effective than the other? When and how to use it? Can we envisage a calmer autumn in pediatric hospital services? Professor Christèle Gras-le Guen, Head of the Pediatric Emergency and General Pediatrics Department at Nantes University Hospital, is the guest of Margaux de Frouville and Alain Ducardonnet.
The mere mention of their name can lead to reactions, such as the desire to scratch: lice are the phobia of many adults, either because they are confronted with them as parents, long live the start of the school year, or because they revive an unpleasant childhood memory. Only those who have experienced it know the hell they represent. There are three types of lice, head lice, body lice and pubic lice. We have chosen to focus more specifically on pediculosis of the head. This is the scientific name given to parasitic infestation of the scalp. What does a louse look like? How are they transmitted? Does it still itch? Are there lice heads? And above all how to get rid of it? We ask all these questions to Professor Olivier Chosidow, member of the French Society of Dermatology of which he is the former president and President of the dermatology evidence center.
It is the health alert which animated the summer period, the circulation of MPox, or monkey pox is closely monitored by the world authorities but also French. The outbreak has been declared a “public health emergency of international concern” by the WHO. In less than a week, the High Authority of Health updated its vaccination recommendations. The General Directorate of Health has clarified the strategy to combat the epidemic. And the infectious diseases research agency, ANRS, presented all the latest news from Mpox, with African, French and Swiss specialists. In short, everyone is showing their mobilization but what is the real risk of an epidemic rebound in France? How is Mpox transmitted? What treatments are available? How effectively? Why is it not recommended for travelers to a country at risk to be vaccinated? We ask all these questions to Professor Jean Daniel Lelièvre, immunologist, head of the infectious and tropical diseases department at the Henri Mondor hospital in Créteil, vaccination specialist with the HAS and the European Medicines Agency and Caroline Dieudonné, journalist health BFMTV, will tell us how screening and vaccination work.
Long Covid affected, or had affected, more than two million French people at the end of 2022, or 4% of adults. The estimate is vague as the definitions of this post-covid syndrome vary according to the World Health Organization, the High Authority for Health or even the Ministry of Health. Fatigue, shortness of breath, headaches, difficulty concentrating, digestive disorders, loss of smell… The manifestations of long Covid are numerous and varied. More than 200 symptoms have already been associated with it. Signs that appear more or less late, more or less strongly. How to explain it? Where is the research? How many people are still affected? How to take care of them? Professor Dominique Salmon-Céron, infectious disease specialist and expert at the High Authority for Health answers us.
